Beaird Harris Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Beaird Harris Wealth Management's ABBV Position: Q2 2026 in Review
Beaird Harris Wealth Management increased its AbbVie (ABBV) stake by 0.13% in Q2 2026, buying an estimated $861 and bringing the position to 3,016 shares worth $759K. The position accounts for 0.05% of the portfolio, ranked #79.
Beaird Harris Wealth Management first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Beaird Harris Wealth Management held 3,016 shares of AbbVie worth $759K as of Q2 2026.
- Beaird Harris Wealth Management bought 4 AbbVie shares in Q2 2026, an estimated $861.
- AbbVie made up 0.05% of Beaird Harris Wealth Management's portfolio in Q2 2026, its #79 holding.
- Beaird Harris Wealth Management first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
- 4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Beaird Harris Wealth Management's 13F filing for Q2 2026, filed 8 Jul 2026.